Personal profile

Research

Innate host defense molecules as biomarkers and therapeutic targets in chronic airway inflammation

COPD, asthma, and cystic fibrosis (CF) together affect a large number of individuals and no curative treatments are available. These diseases have in common that they start at the airway mucosal surfaces and inflammatory bouts (exacerbations) are to a large extent triggered by infections. In this project, we study innate host defense, with a focus on roles for chemokines and innate antibiotics during airway inflammation. These molecules are important both in the context of the prolonged and dysregulated inflammation as well as during the exacerbations seen COPD, asthma, and CF.

The project applies experimental models reflecting mucosal inflammation as well as investigation of clinical samples. The production of antibacterial chemokines by inflamed epithelial cells demonstrates an important aspect of innate immunity. It is therefore important to increase the knowledge concerning mechanisms regulating their expression in airway epithelial cells. In addition, antibacterial chemokines can serve as both biomarkers and templates to develop new treatment strategies against inflammatory bouts of COPD, asthma, and CF.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Subject classification (UKÄ)

  • Respiratory Medicine and Allergy

Free keywords

  • COPD; Asthma; Cystic fibrosis; Innate immunity; Host defense

Fingerprint

Dive into the research topics where Arne Egesten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or